| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 06/08/2011 | CN1926097B Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 06/08/2011 | CN102089279A Biaryl PDE4 inhibitors for treating inflammation |
| 06/08/2011 | CN102089278A Compounds and compositions useful for the treatment of malaria |
| 06/08/2011 | CN102086166A 3-methoxy-4-(N-substituted amino sulfonyl)fenalamide compounds and application thereof |
| 06/08/2011 | CN101454002B Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
| 06/08/2011 | CN101395140B Method for producing 2-imidazolidinone compound and 4,5-dialkoxy-2-imidazolidinone compound |
| 06/08/2011 | CN101203522B Antineoplastic compounds and pharmaceutical compositions thereof |
| 06/08/2011 | CN101190916B Anticancer compound, preparation method and use thereof, and composition containing the compound |
| 06/07/2011 | US7956195 reacting arylboronic acids with a cycloalkanone, in the presence of a rhodium catalyst or BINAP, to form a substituted arylcycloalkanone, then formin of a hydantoin, alkylation of the hydantoin, resolution, hydrolysis of the hydantoin to the amino acids and esterification of acids; chemical intermediates |
| 06/07/2011 | US7956076 Ribonucleotide reductase inhibitors and methods of use |
| 06/07/2011 | US7956075 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/07/2011 | US7956071 Imidazole compounds |
| 06/07/2011 | US7956066 Imidazole compounds |
| 06/07/2011 | US7956057 Imidazole compounds |
| 06/03/2011 | WO2011014613A3 Preparation of fipamezole |
| 06/03/2011 | WO2010149675A3 Method of synthesizing organic molecules |
| 06/02/2011 | US20110130391 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 06/01/2011 | EP2327707A1 Ionic compound, process for producing same, and ion-conductive material comprising same |
| 06/01/2011 | EP1981854B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/01/2011 | CN102083823A Method for producing 1-biphenylmethylimidazole compound |
| 06/01/2011 | CN102083811A 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| 06/01/2011 | CN102083803A Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof |
| 06/01/2011 | CN102083798A Ruthenium olefin metathesis catalysts bearing N-heterocyclic carbene ligands with substituted backbone |
| 06/01/2011 | CN102083793A Protease inhibitors |
| 06/01/2011 | CN102079729A Compounds with antiparasitic activity and medicaments containing them |
| 06/01/2011 | CN102079724A Ethylene sulfonyl chloride azole compounds with anti-microbial activity as well as preparation method and medical use thereof |
| 06/01/2011 | CN101076520B Imidazoline derivatives having cb1-antagonistic activity |
| 05/31/2011 | US7951972 Human adam-10 inhibitors |
| 05/31/2011 | US7951958 Imidazole compounds for the treatment of neurodegenerative disorders |
| 05/31/2011 | US7951846 pH-sensitive polymeric micelles for drug delivery |
| 05/31/2011 | US7951830 Compounds effecting glucokinase |
| 05/31/2011 | US7951808 Imidazole compounds |
| 05/31/2011 | CA2555745C Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors |
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/26/2011 | WO2011063261A2 Pathogen protection garment with both rapid and persistent rechargable self-sterilization |
| 05/26/2011 | US20110124877 5-benzyl-4-azolylmethyl-4-spiro[2.4]heptanol derivatives, methods for producing the same, and agro-horticultural agents and industrial material protecting agents thereof |
| 05/26/2011 | US20110124868 Ruthenium olefin metathesis catalysts bearing n-heterocyclic carbene ligands with substituted backbone |
| 05/26/2011 | US20110123976 Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using NMR |
| 05/25/2011 | EP2324830A1 Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage |
| 05/25/2011 | EP2323990A1 Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof |
| 05/25/2011 | EP1711472B1 Mehtod for producing ionic liquids |
| 05/25/2011 | CN1972718B Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 05/25/2011 | CN1926116B Method for the production of compounds with quaternary sp<2>-hybridised nitrogen atoms |
| 05/25/2011 | CN1849330B Specific glucocorticosteroid compound having anti-inflammatory activity |
| 05/25/2011 | CN1578663B Inhibitors of histone deacetylase |
| 05/25/2011 | CN102070533A New method for synthesizing 4-(1-hydroxyl-1-methyl ethyl)-2-propyl imidazole-5-carboxylic acid ethyl ester |
| 05/25/2011 | CN102070532A Anti-tumor medicament structure |
| 05/25/2011 | CN102070531A Microwave radiation injury protection medicines |
| 05/25/2011 | CN102070530A N-alkylamino-2-perfluoroalkylimidazoline quaternary ammonium salt and preparation method thereof |
| 05/25/2011 | CN102070529A Axially chiral imidazole salt compound and preparation method thereof |
| 05/25/2011 | CN101585812B Preparation method of (S) type thioic imidazolone compound |
| 05/25/2011 | CN101508675B Novel disulfonic acid type alkyl imidazole ionic liquid, preparation and uses thereof |
| 05/25/2011 | CN101250160B Chloride 1,3-di(2-hydroxy ethyl) imidazole ionic liquid and method for synthesizing same |
| 05/25/2011 | CN101108827B Method for manufacturing acetic acid type ionic liquid |
| 05/24/2011 | US7947854 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds |
| 05/24/2011 | US7947841 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide |
| 05/24/2011 | US7947722 Imidazolidinone derivative, method of producing the same and method of producing optically active amino acid |
| 05/24/2011 | US7947713 Tripeptidyl peptidase inhibitors |
| 05/24/2011 | CA2472821C Process for producing fused imidazole compound, and reformatsky reagent in stable form and process for producing the same |
| 05/24/2011 | CA2441235C Aryl and biaryl compounds having mch modulatory activity |
| 05/19/2011 | WO2011059731A1 Alkynyl derivatives useful as dpp-1 inhibitors |
| 05/19/2011 | WO2011059048A1 Novel amide derivative |
| 05/19/2011 | WO2010149598A3 Heterocyclic antiviral compound |
| 05/19/2011 | US20110118325 Rel inhibitors and methods of use thereof |
| 05/19/2011 | US20110118244 Factor xa inhibitors |
| 05/19/2011 | US20110118219 Novel prodrugs of c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
| 05/19/2011 | US20110118199 Use of cns penetrating anticancer compounds for the treatment of protozoal diseases |
| 05/19/2011 | CA2781056A1 Kinase inhibitors |
| 05/18/2011 | EP2321281A2 Anti inflammatory compounds |
| 05/18/2011 | EP2101762B1 Novel 2 -imidazoles as ligands for trace amine associated receptors (taar) |
| 05/18/2011 | EP1698618B1 Benzamide derivative |
| 05/18/2011 | EP1667984B1 Gamma-secretase inhibitors |
| 05/18/2011 | EP1318140B1 Novel amide derivatives and medicinal use thereof |
| 05/18/2011 | CN1727340B Temozolomide 8-carboxylic ester, and combination |
| 05/18/2011 | CN102066322A Compound having NPY Y5 receptor antagonist activity |
| 05/18/2011 | CN102060793A Dual aryl tertiary amine azole compounds with biological activity as well as preparation method and medical application thereof |
| 05/18/2011 | CN102060778A Method for synthesizing 4-(1-hydroxyl-1-methylethyl)-2-propyl iminazole-5-carboxylic ethyl ester |
| 05/18/2011 | CN102060777A Novel phenytoin medicament eutecticum and preparation method thereof |
| 05/18/2011 | CN102060776A Antioxidant ionic liquid containing sterically hindered phenol and preparation method and use thereof |
| 05/18/2011 | CN102060775A Preparation method of imidazole ion liquid |
| 05/18/2011 | CN102060738A Ionic liquid combining B acid site and L acid site as well as preparation method and application thereof |
| 05/18/2011 | CN101490013B Method for producing imidazolidine-2,4-dione compound and method for obtaining solid 4,5-dihydroxy-2-imidazolidinone compound |
| 05/18/2011 | CN101215263B Preparation of catalyst CRBA used for biodegradation polymer synthesis |
| 05/18/2011 | CN101189212B Process for the synthesis of organic compounds |
| 05/17/2011 | US7943779 Process for the preparation of olmesartan medoxomil |
| 05/17/2011 | US7943625 2 thioxanthine derivatives acting as MPO-inhibitors |
| 05/12/2011 | WO2011056895A1 Ionic liquids comprising heteraromatic anions |
| 05/12/2011 | WO2011056652A1 Imidazole derivatives as ido inhibitors |
| 05/12/2011 | WO2011005969A3 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
| 05/12/2011 | WO2010116166A3 Process for the preparation of chalcogene compounds |
| 05/12/2011 | US20110112303 Process |
| 05/12/2011 | US20110112293 Purification Strategy for Direct Nucleophilic Procedures |
| 05/12/2011 | US20110112151 Compound capable of inhibiting 11-beta hydroxysteriod dehydrogenase |
| 05/12/2011 | US20110112097 Substituted imidazoline-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 05/12/2011 | CA2778115A1 Imidazole derivatives as ido inhibitors |
| 05/11/2011 | EP2318375A1 Imidazole carboxamides |
| 05/11/2011 | EP2318374A2 Insecticidal benzenedicarboxamide derivative |
| 05/11/2011 | EP1411929B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/11/2011 | EP1320520B1 Sulfonylguanidine |
| 05/11/2011 | CN102056903A New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |